ABL logo

ABL

Abacus Life Inc.

$5.81
+$0.19(+3.38%)
46
Overall
60
Value
33
Tech
--
Quality
Market Cap
$602.84M
Volume
600.14K
52W Range
$4.60 - $9.61
Target Price
$13.10

Company Overview

Mkt Cap$602.84MPrice$5.81
Volume600.14KChange+3.38%
P/E Ratio-25.2Open$5.63
Revenue$111.9MPrev Close$5.62
Net Income$-24.0M52W Range$4.60 - $9.61
Div Yield0.20%Target$13.10
Overall46Value60
Quality--Technical33

No chart data available

About Abacus Life Inc.

Abacus Global Management, Inc. operates as an alternative asset manager and market maker in the United States. It operates through five segments: Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. The Active Management segment is involved in buying, selling, and trading policies and maintaining policies until receipt of death benefits. The Originations segment originates life insurance policy settlements between investors or buyers, and the sellers, who is often the original policy owners. The Asset Management segment provides asset management services to investors investing in alternative investment and equity portfolio funds based on fund investment agreements. The Portfolio Servicing segment offers policy services to customers on a contract basis. The Technology Services segment provides real-time mortality verification, missing participant verification, and other services specific to the life insurance market services to customers on a contract basis. It sells its products through financial advisors or agents, direct to consumer, and traditional life settlements intermediaries. The company was formerly known as Abacus Life, Inc. and changed its name to Abacus Global Management, Inc. in February 2025. Abacus Global Management, Inc. was founded in 2004 and is headquartered in Orlando, Florida.

Latest News

Abacus Life (ABL) Gets a Buy from Maxim Group

Maxim Group analyst Michael Diana reiterated a Buy rating on Abacus Life today and set a price target of $14.00. Diana covers the Financial sector,...

TipRanks Auto-Generated Intelligence Newsdesk12 days ago

Analysts Conflicted on These Technology Names: N-able (NABL) and CyberArk Software (CYBR)

Brian Anderson17 days ago

TD Cowen Reaffirms Their Buy Rating on Abbott Laboratories (ABT)

TipRanks Auto-Generated Intelligence Newsdeska month ago
ABCD
1SymbolPriceChangeVol
2ABL$5.81+3.4%600.14K
3
4
5
6

Get Abacus Life Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.